VEGFD |
Vascular endothelial growth factor D precursor |
rno04060:Cytokine–cytokine receptor interaction; rno04150:mTOR signalling pathway, rno04510:Focal adhesion |
0.44 |
0.54 |
VGFR2 |
Vascular endothelial growth factor receptor 2 precursor |
rno04060:Cytokine–cytokine receptor interaction; rno04144:Endocytosis |
0.63 |
0.63 |
KPCB |
Protein kinase C beta type |
rno04010:MAPK signalling pathway; rno04012:ErbB signalling pathway; rno04020:Calcium signalling pathway |
0.60 |
0.51 |
ARAF |
A‐Raf proto‐oncogene serine/threonine‐protein kinase |
|
1.78 |
1.66 |
RASN |
GTPase NRas precursor |
rno04010:MAPK signalling pathway; rno04012:ErbB signalling pathway |
2.39 |
2.96 |
NOS3 |
Nitric‐oxide synthase, endothelia |
rno00330:Arginine and proline metabolism; rno04020:Calcium signalling pathway |
0.40 |
0.58 |
PLCG2 |
Phospholipase C‐gamma‐2 |
no00562:Inositol phosphate metabolism; rno04012:ErbB signalling pathway, rno04020:Calcium signalling |
0.70 |
0.74 |
KPCT |
Protein kinase C theta type |
rno04270:Vascular smooth muscle contraction; rno04530:Tight junction; rno04920:Adipocytokine signalling pathway |
0.61 |
0.64 |
NOS1 |
Nitric‐oxide synthase |
rno00330:Arginine and proline metabolism; rno04020:Calcium signalling pathway |
0.88 |
0.86 |
PLCG1 |
Phospholipase C‐gamma‐1 |
rno00562:Inositol phosphate metabolism; rno04012:ErbB signalling pathway; rno04020:Calcium signalling |
0.87 |
1.01 |
KPCZ |
Protein kinase C zeta typ |
rno04144:Endocytosis; rno04530:Tight junction; rno04910:Insulin signalling pathway |
0.57 |
0.77 |